Sanofi-GSK reports success in virus vaccine, after setback

Sanofi and GlaxoSmithKline's potential Covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year.



May 17, 2021 at 01:35PM